Emerging Role of Dual and Triple Agonists in Liver Disease Treatment | Retatrutide News

Dual and triple agonists are emerging as promising therapies for metabolic liver diseases. These agents, including Retatrutide, target multiple pathways...
Clinical Trials · November 4, 2026